Genting to develop first stem cell facility in Bali, expand into healthcare
Fontaine Vitale will be the first in Asean to offer placenta-derived allogeneic stem cell therapy
[KUALA LUMPUR] Malaysian conglomerate Genting has launched its first stem cell facility in Bali, Indonesia, marking a significant milestone in its expansion into advanced healthcare and medical tourism.
The Fontaine Vitale facility, located in the Sanur Special Economic Zone (SEZ), will be operated by Genting’s 56-per-cent-owned indirect subsidiary Astana Bangun Sejahtera, in partnership with Indonesian companies Sentosa Bersama Mitra and Bintang Graha Hijau.
Fontaine Vitale will also collaborate with US-based Celularity to integrate cutting-edge expertise in cellular and regenerative medicine, bringing advanced therapies and treatments to the region.
In a statement on Thursday (Nov 21), Lim Kok Thay, chairman and chief executive of Genting, said that this venture underscores the group’s commitment to diversifying its portfolio and entering the healthcare sector.
The four-storey facility will span 9,121 square metres on land leased for 30 years from Hotel Indonesia Natour.
It will be developed in two phases, featuring a manufacturing unit and a stem cell clinic offering advanced cell therapy services, including wellness aesthetic and regenerative medicine using placenta-derived stem cells.
The facility will also showcase diagnostic products developed by companies in Genting’s life sciences portfolio, including enhanced imaging with artificial intelligence solutions to help improve disease prediction and diagnosis, as well as tools for early diagnosis and monitoring of disease progression in dementia.
Tan Kong Han, Genting president, chief operating officer and executive director, noted that the stem cell clinic is expected to commence operations by end-2026.
Once operational, it will be the first in Asean to offer placenta-derived allogeneic stem cell therapy, focusing on well-being, aesthetics and regenerative medicine, he added.
The Sanur SEZ, Indonesia’s first medical tourism-focused zone, is part of the government’s initiative to create a comprehensive health and wellness ecosystem.
The zone is designed to attract both domestic and international patients with advanced medical facilities and a serene environment.
“We believe this facility will not only enhance the healthcare landscape in Asean, but also position Bali as a key hub for medical tourism, attracting patients from around the world seeking cutting-edge regenerative therapies,” added Tan.
